Wilson Sonsini Goodrich & Rosati represents Pacific Biosciences of California, Inc. on the transaction. Pacific Biosciences of California, Inc. (PacBio) (NASDAQ: PACB), a leading developer of...
PacBio’s $459 Million Convertible Note Exchange Offering
Pacific Biosciences’ Acquisition of Apton Biosystems
Wilson Sonsini Goodrich & Rosati is representing Pacific Biosciences, and Fenwick & West is representing Apton Biosystems in the transaction. 8Pacific Biosciences of California (NASDAQ: PACB) (PacBio) announced...
PacBio’s $441 Million Senior Notes Offering
Wilson Sonsini Goodrich & Rosati advised PacBio in the offering. Pacific Biosciences of California, Inc. (PacBio) (NASDAQ: PACB) announced that it has entered into a privately negotiated...
Pacific Biosciences’ $201.25 Million Stock Offering
Wilson Sonsini advised Pacific Biosciences of California on the offering, and Davis Polk advised the representatives of the several underwriters involved. Pacific Biosciences of California Inc. announced...